MIRGX
Price
$39.32
Change
+$0.19 (+0.49%)
Updated
Aug 21 closing price
Net Assets
8.65B
RGAEX
Price
$86.79
Change
+$0.78 (+0.91%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

MIRGX vs RGAEX

MIRGX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
MIRGX vs. RGAEX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRGX is a StrongBuy and RGAEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 342B vs. MIRGX (8.65B). RGAEX pays higher dividends than MIRGX: RGAEX (0.22) vs MIRGX (0.12). MIRGX was incepted earlier than RGAEX: MIRGX (23 years) vs RGAEX (24 years). MIRGX (0.96) is less costly to investors than RGAEX (0.63). RGAEX is a more actively managed with annual turnover of: 32.00 vs. MIRGX (21.00). MIRGX has a lower initial minimum investment than RGAEX: MIRGX (0) vs RGAEX (250). RGAEX annual gain was more profitable for investors over the last year : 5.47 vs. MIRGX (-6.71). RGAEX return over 5 years is better than : 16.97 vs. MIRGX (-6.45).
MIRGXRGAEXMIRGX / RGAEX
Total Expense Ratio0.960.63152%
Annual Report Gross Expense Ratio0.960.63152%
Fund Existence23 years24 years-
Gain YTD-0.4819.404-5%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.65B342B3%
Annual Yield % from dividends0.120.2255%
Returns for 1 year-6.715.47-123%
Returns for 3 years9.8446.9821%
Returns for 5 years-6.4516.97-38%
Returns for 10 years62.68100.9662%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWEX108.151.60
+1.50%
American Funds New World R-4
CMJIX53.180.37
+0.70%
Calvert US Mid Cap Core Rspnb Idx I
PSSJX27.190.18
+0.67%
Principal SmallCap S&P 600 Index J
SVFCX99.570.66
+0.67%
Smead Value C
CRRVX10.78-0.01
-0.09%
Columbia Real Estate Equity Inst2